Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Trabectedin × Sarcoma × Clear all

Phase

Status

Completed 27 Recruiting 7 Terminated 5 Unknown 3 Withdrawn 2 No longer available 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 17 Nivolumab 15 pembrolizumab 14 Specimen Handling 14 Magnetic Resonance Spectroscopy 14 Temozolomide 11 Radiotherapy 11 Doxorubicin 11 Radiation 10 Biopsy 10 X-Rays 8 Ipilimumab 8 Phantoms, Imaging 7 Etoposide 7 Bevacizumab 7 fludarabine 6 cabozantinib 6 Sirolimus 6 Irinotecan 6 Ifosfamide 6 palbociclib 5 olaparib 5 Radiosurgery 5 Carboplatin 5 talimogene laherparepvec 4 pazopanib 4 fludarabine phosphate 4 durvalumab 4 atezolizumab 4 Vinorelbine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06263231 2025-07-29

INVINCIBLE-3

Intensity Therapeutics, Inc.

Phase 3 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡